{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:17:13Z","timestamp":1788891433898,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,28]]},"DOI":"10.7759\/cureus.84970","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:05:11Z","timestamp":1748441111000},"source":"Crossref","is-referenced-by-count":2,"title":["Tumor Necrosis Factor-Alpha Inhibitor-Induced Sarcoid-Like Reaction in a Patient With Juvenile Idiopathic Arthritis: A Case Report"],"prefix":"10.7759","author":[{"given":"Thanda","family":"Aung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Prasanpanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Eblen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve P","year":"2021","unstructured":"S\u00e8ve P, Pacheco Y, Durupt F, et al.. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. 2021, 10:10.3390\/cells10040766","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23870","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis","volume":"71","author":"Ringold S","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, et al.. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Care Res (Hoboken). 2019, 71:717-34. 10.1002\/acr.23870","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-022-00424-1","article-title":"Anti-TNF induced sarcoidosis-like disease in rheumatoid arthritis patients: review cases from the RA UCLouvain Brussels cohort","volume":"9","author":"Theunssens X","year":"2022","unstructured":"Theunssens X, Bricman L, Dierckx S, Sapart E, Sokolova T, Avramovska A, Durez P. Anti-TNF induced sarcoidosis-like disease in rheumatoid arthritis patients: review cases from the RA UCLouvain Brussels cohort. Rheumatol Ther. 2022, 9:763-70. 10.1007\/s40744-022-00424-1","journal-title":"Rheumatol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1065","article-title":"Pulmonary sarcoidosis with a cavitary lesion in the lung caused by a TNF-\u03b1 inhibitor: a case report","volume":"10","author":"Hamada E","year":"2022","unstructured":"Hamada E, Yamamoto Y, Okuda Y, et al.. Pulmonary sarcoidosis with a cavitary lesion in the lung caused by a TNF-\u03b1 inhibitor: a case report. Respirol Case Rep. 2022, 10:e01065. 10.1002\/rcr2.1065","journal-title":"Respirol Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Da\u00efen CI","year":"2009","unstructured":"Da\u00efen CI, Monnier A, Claudepierre P, et al.. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford). 2009, 48:883-6. 10.1093\/rheumatology\/kep046","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2011.02612.x","article-title":"New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication","volume":"42","author":"Tong D","year":"2012","unstructured":"Tong D, Manolios N, Howe G, Spencer D. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication. Intern Med J. 2012, 42:89-94. 10.1111\/j.1445-5994.2011.02612.x","journal-title":"Intern Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12991","article-title":"Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database","volume":"288","author":"Cohen Aubart F","year":"2020","unstructured":"Cohen Aubart F, Lhote R, Amoura A, Valeyre D, Haroche J, Amoura Z, Lebrun-Vignes B. Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database. J Intern Med. 2020, 288:356-62. 10.1111\/joim.12991","journal-title":"J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.03.004","article-title":"Pulmonary sarcoidosis: diagnosis and treatment","volume":"91","author":"Carmona EM","year":"2016","unstructured":"Carmona EM, Kalra S, Ryu JH. Pulmonary sarcoidosis: diagnosis and treatment. Mayo Clin Proc. 2016, 91:946-54. 10.1016\/j.mayocp.2016.03.004","journal-title":"Mayo Clin Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra A","year":"2018","unstructured":"Chopra A, Nautiyal A, Kalkanis A, Judson MA. Drug-induced sarcoidosis-like reactions. Chest. 2018, 154:664-77. 10.1016\/j.chest.2018.03.056","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw155","article-title":"Sarcoidosis-like lesions: another paradoxical reaction to anti-TNF therapy?","volume":"11","author":"Decock A","year":"2017","unstructured":"Decock A, Van Assche G, Vermeire S, Wuyts W, Ferrante M. Sarcoidosis-like lesions: another paradoxical reaction to anti-TNF therapy?. J Crohns Colitis. 2017, 11:378-83. 10.1093\/ecco-jcc\/jjw155","journal-title":"J Crohns Colitis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000800","article-title":"Drug-induced sarcoidosis-like reactions","volume":"27","author":"Miedema J","year":"2021","unstructured":"Miedema J, Nunes H. Drug-induced sarcoidosis-like reactions. Curr Opin Pulm Med. 2021, 27:439-47. 10.1097\/MCP.0000000000000800","journal-title":"Curr Opin Pulm Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.11.003","article-title":"Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new \"class effect\" paradoxical phenomenon. Two case reports and literature review","volume":"39","author":"Massara A","year":"2010","unstructured":"Massara A, Cavazzini L, La Corte R, Trotta F. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new \"class effect\" paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. 2010, 39:313-9. 10.1016\/j.semarthrit.2008.11.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS Clinical Statement on pulmonary sarcoidosis","volume":"76","author":"Thillai M","year":"2021","unstructured":"Thillai M, Atkins CP, Crawshaw A, et al.. BTS Clinical Statement on pulmonary sarcoidosis. Thorax. 2021, 76:4-20. 10.1136\/thoraxjnl-2019-214348","journal-title":"Thorax"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals M","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, et al.. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007, 86:242-51. 10.1097\/MD.0b013e3181441a68","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/365620-tumor-necrosis-factor-alpha-inhibitor-induced-sarcoid-like-reaction-in-a-patient-with-juvenile-idiopathic-arthritis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:05:11Z","timestamp":1748441111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/365620-tumor-necrosis-factor-alpha-inhibitor-induced-sarcoid-like-reaction-in-a-patient-with-juvenile-idiopathic-arthritis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.84970","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}